The financial bloodbath continued in the aftermath of the Brexit with the Dow plummeting 264 points to 17,136. Nasdaq plunged 86 points to 4,621.
On the upside
Medtronic will pay a premium of approximately $1.1 billion in cash to acquire Heartware International (Nasdaq: HTWR).
GW Pharmaceuticals (Nasdaq: GWPH) reported positive Phase 3 results for Epidiolex to treat Lennox-Gastaut syndrome.
Skullcandy (Nasdaq: SKUL) received an unsolicited acquisition offer from Mill Road Capital that topped the $177 million bid from Incipio.
On the downside
Analysts downgraded Barclays (NYSE: BCS), Lloyds Banking (NYSE: LYG) and Royal Bank of Scotland (NYSE: RBS).
Ford (NYSE: F) dealers in Indonesia demanded $75 million in compensation after the automaker suddenly announced in January that all operations would close in that country.
Concerns that the Brexit will increase costs for U.K. airlines weighed down shares of Ryanair (Nasdaq: RYAAY).
In the broad market, declining issues outpaced advancers by a margin of more than 5 to 1 on the NYSE and by nearly 5 to 1 on Nasdaq. The broader S&P 500 tumbled 34 points to 2,002. Bitcoin rose $5 to $622.
